![](/imager/uploads/logos/58681/Avicenna_logo_black_117378e58441a39758ec294c229f7090.webp)
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
Synthetic DNA is an important emerging tool in clinical medicine, pharmaceuticals, agriculture, and food. Yet research is being held back by traditional DNA synthesis techniques, which can produce only short segments of DNA. Molecular Assemblies has created an evolved polymerase enzyme that can rapidly synthesize ultra-long oligonucleotide chains with 150 or more nucleotide bases. The enzyme also eliminates the time required for purification by weeding out incomplete oligos as it goes.
Using AI to speed through the last mile of drug discovery
Finding precisely tuned viral vectors for gene therapy in CNS disorders
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing